Transmasculine Guide: Risks
Risks/Side effects
Section titled “Risks/Side effects”For a full list of potential increased risks of certain health issues associated with transmasculine HRT, you can refer to this resource.
Most of the serious side effects are extremely low in absolute risk.
Polycythemia
Section titled “Polycythemia”Polycythemia (high concentration of red blood cells in the blood) is a unique risk for transmascs taking any testosterone therapy. CBC (complete blood count) tests to monitor your hematocrit (red blood cell count) are recommended. Polycythemia can result in increased risk of thrombosis (blood clots).
Aromatization
Section titled “Aromatization”In all people, a small portion of the testosterone in their bodies is converted into estradiol (estrogen) through a process called aromatization. In most men, testosterone levels will typically remain within a range that does not cause a significant increase in estradiol levels, thereby mitigating any unwanted feminizing effects.
As a transmasculine person, it’s important to not take too much testosterone (please stay within recommended dosage guidelines) to prevent estradiol levels from getting too high (which can cause unwanted feminizing effects such as breast development, especially if you haven’t gone through a complete natal estrogen puberty).
As long as you take reasonable dosages of testosterone and do not go over the recommended dosages, you are unlikely to deal with excessive aromatization.